Publications by authors named "M Niebuhr"
Objective: To compare operative and oncological outcomes, as well as the risk of postoperative complications in patients who underwent transperitoneal robot-assisted partial nephrectomy (RAPN) for renal tumours located either posteriorly or anterolaterally.
Methods: Retrospective, consecutive study including 451 patients who underwent transperitoneal RAPN for non-metastatic, localised renal tumours from May 2016 to April 2023. Operative data included duration of the procedure, warm ischaemia time, and blood loss; oncological data included surgical margins and recurrence; and 90-day postoperative complications were classified according to the Clavien-Dindo classification.
Background: There is a lack of evidence concerning recurrent patterns and treatment of repeat recurrences for surgically treated renal cell carcinoma (RCC). Thus, the objective was to describe patterns of recurrences and subsequent treatments in patients with recurrent RCC.
Patients And Methods: We identified 525 patients who received surgical treatment for RCC at our institution in 2010-2015.
Article Synopsis
- The study investigates the outcomes of robot-assisted laparoscopic Anderson-Hynes pyeloplasty (RALP) for treating ureteropelvic junction obstruction using the DaVinci Si surgical system, focusing on surgical and functional results.
- A total of 194 patients were analyzed, revealing that 33% faced postoperative complications, while the 1-year success rates varied from 78% to 92% based on the underlying condition for surgery.
- The findings conclude that RALP is a safe procedure with minimal major complications and an overall acceptable success rate for treating the condition.
Background & Aim: More elderly patients are diagnosed with kidney tumors where partial nephrectomy is technically possible. We investigated whether patients ≥ 75 years old had an increased risk of complications following robot-assisted partial nephrectomy (RAPN) compared to younger patients.
Methods: Retrospective, consecutive study including patients who underwent RAPN between May 2016 - April 2023.